Phylogica patent allowed
Thursday, 29 September, 2005
Perth-based Phylogica (ASX:PYC) has received formal notice of allowance from the European Patent and Trademark Office for its pending patent application entitled: "Isolating biological modulators from biodiverse gene fragment libraries".
The application was filed in 2000 and protects Phylogica's core peptide library technology. Phylogica's proprietary libraries contain millions of phylomers - stable fragments of naturally occurring proteins.
"Not only are the methods for creating these libraries covered but this foundation patent application also describes methods for increasing the diversity of the libraries further," said Phylogica's scientific director Dr Paul Watt in a statement.
Phylogica has eight patent families and cases from the patent family of this recently allowed application have already been granted in Australia and allowed in the US.
$780m Sydney Biomedical Accelerator gains its founding Executive Director
Professor Victoria Cogger has been appointed as founding Executive Director of the Sydney...
Portable point-of-care test detects four common STIs in under an hour
Australian researchers have developed a portable point-of-care test that detects four common...
AusBiotech and Proto Axiom partner on investor-focused life sciences programs
AusBiotech and Proto Axiom have announced a partnership to strengthen national coordination...
